PainChek General Discussion, page-3375

A few specific points on this BN.

(by the way - how did you hear about the company and actually end up on the PCK boards?)

1.I've learned to ignore the psychology of the market.

The 'potential opportunities' you mention at this end of the market are few and far between.

Putting it bluntly, the majority of microcaps and small caps on the ASX are complete turds with no prospects and disingenuous management. Money can be made trading them, but one can easily be left holding the bag(of turds).

2.PCK still has a MC of less than $200 million (I still think that is massively undervalued).

It's not 'hard to justify its current valuation', but rather you struggle to justify that MC based on the traditional valuation metrics that you apply to value companies that you usually invest in.

PCK is however hard to value; the market is trying to factor in huge potential growth to the SP. The market has no way of knowing how large that growth will be, and how long it will take. We as investors use all the information we have at hand to make that call.

When PCK is compared to other speculative microcaps and small caps with similar potential growth it is not an outlier in terms of MC.

3.Re. 'the way some people got defensive/offensive'.

It's frustration caused by a value investor bowling into a speculative small cap discussion thread and telling the thread about huge risks and bubbles popping with nothing to back it up.

We know, that's why we are here. Captain Obvious is not required.

If you're going to 'urge caution' on a small cap without any rational points as to why, then you're going to get burned hard.

4.Re. 'posting the companies balance sheet shouldn’t get people angry'.

It doesn't.

Posting it with a lack of understanding of its context and calling people 'mullets' does.

Imay have posted the same figures previously in the thread, many of us have posted various extracts from PCK's financials.

We've all seen the balance sheet. We know the figures. We know the announcements inside out. PCK is a new company bringing a new product to market...of course PCK was losing money!

Again,Captain Obvious is not required. Tell us something we don't know and we'll listen.

5.Re. the specific numbers you mention.

Lots of posters here have crunched a few numbers on an informal basis.

However due to the novel nature of the product/service that PCK offers, it can be tricky.

Youwill have to go and find that information and/or work it out yourself.

Independent broker reports? Never heard of them!

Welcome to the world of speculative small caps.

It's harder work down at this end of town, and if you CBA/F then there are plenty of good value stocks on the ASX waiting for you, with their several years of robust historical financials and their independent broker coverage.

6.I only know you through what you have written on HC about PCK.

Judging by the way you write and the way you seem to analyse companies, it sounds like speculative stocks don't really suit you. That's ok.Everybody is different. Good luck whatever you choose.

7.Finally I'll leave you with my summary from a previous post.

Simply it explains why the market is massively bullish on PCK right now.

I can't find another company on the ASX this well positioned to transition from a speculative stock to a (profitable) growth stock.

Facts:
-product with proven efficacy (peer reviewed journals)
- zero competition (literally no competitors operating in the dementia pain assessment market currently)
- target market of approximately 17million users (high income countries dementia sufferershttps://www.alz.co.uk/research/statistics)
- regulatory approval in Australia
- regulatory approval in Europe

-fully commercialised product
- revenue generated and growing
-Aus goverment funding of AUD $5 million to get to market (real funding, not R&D tax rebates or exploration incentives)
-quality management with proven track record in same field (Mr.Daffas, look up his resume)
- operating both domestically and internationally (Aus and UK)
- zero churn (as stated by MD Daffas in video interview)
- broken even already (30,000 beds was the break even I think)
- less than $200 million MC
-the major shareholders have just committed an additional AUD $4.15million to fast track international expansion (at near record highs for the share price)